 GSK PLC LSE:GSK, NYSE:GSKs third quarter results beat City expectations according to broker UBS which said turnover of 7,829mln was 7 ahead of consensus with adjusted operating profit of 2,605mln, 13 above expectations and adjusted EPS of 46.9p, 17 ahead of the forecast of 40.1p. Vaccines beat forecasts by 3 driven by Shingrix sales of 760mln 11 above consensus while the HIV portfolio with sales of 1,486m was slightly 1 ahead, the broker said in a note following the numbers. 